| Date Filed | Type | Description |
| 06/16/2023 |
4
| Protopapas Anna (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 01/18/2023 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Gifted 240,244 shares
@ $0
Gifted 240,244 shares
@ $0
Sold 17,346 shares
@ $5.74, valued at
$99.6k
Granted 562,500 options to buy
@ $6.06, valued at
$3.4M
Granted 125,000 restricted stock units
@ $0
Exercised 16,750 restricted stock units
@ $0
Exercised 21,250 restricted stock units
@ $0
Exercised 17,708 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Protopapas Anna (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 40,000 options to buy
@ $14.08, valued at
$563.2k
|
|
| 03/31/2022 |
3
| Protopapas Anna (Director) has filed a Form 3 on Nuvalent, Inc. |
| 01/19/2022 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 17,708 restricted stock units
@ $0
Exercised 21,250 restricted stock units
@ $0
Granted 301,450 options to buy
@ $6.28, valued at
$1.9M
Granted 67,000 restricted stock units
@ $0 |
|
| 07/19/2021 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 20,043 shares
@ $12.47, valued at
$249.9k
Sold 21,901 shares
@ $12.02, valued at
$263.3k
Exercised 100,000 restricted stock units
@ $0 |
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,198 shares
@ $21.09, valued at
$109.6k
Exercised 17,709 restricted stock units
@ $0
Granted 382,500 options to buy
@ $21.09, valued at
$8.1M
Granted 85,000 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| Protopapas Anna (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $21.61, valued at
$324.2k
|
|
| 01/16/2020 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 318,750 options to buy
@ $6.16, valued at
$2M
Granted 70,833 restricted stock units
@ $0 |
|
| 07/19/2019 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 100,000 restricted stock units
@ $0 |
|
| 06/21/2019 |
4
| Protopapas Anna (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $15.44, valued at
$386k
|
|
| 01/25/2019 |
4
| Protopapas Anna (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $10.31, valued at
$257.8k
|
|
| 01/25/2019 |
3
| Protopapas Anna (Director) has filed a Form 3 on Dicerna Pharmaceuticals Inc |
| 01/25/2019 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 217,500 options to buy
@ $3.51, valued at
$763.4k
|
|
| 03/08/2018 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 1,056 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 23,006 options to buy
@ $52.08, valued at
$1.2M
|
|
| 02/06/2018 |
4
| Protopapas Anna (President & CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $14.23, valued at
$2.8M
|
|
| 02/02/2018 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 5,455 restricted stock units
@ $0 |
|
| 12/21/2017 |
4
| Protopapas Anna (President and CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Exercised 10,417 options to buy
@ $1.53, valued at
$15.9k
|
|
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/17/2017 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc. |
| 03/02/2017 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc. |
| 03/02/2017 |
3
| Protopapas Anna (Director) has filed a Form 3 on Bioverativ Inc. |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |